# Gelatin in ICU and Sepsis

> **NCT02715466** · PHASE4 · TERMINATED · sponsor: **B. Braun Melsungen AG** · enrollment: 167 (actual)

## Conditions studied

- Hypovolemia

## Interventions

- **DRUG:** Balanced gelatine solution
- **DRUG:** Balanced electrolyte solution

## Key facts

- **NCT ID:** NCT02715466
- **Lead sponsor:** B. Braun Melsungen AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04
- **Primary completion:** 2021-12-08
- **Final completion:** 2021-12-08
- **Target enrollment:** 167 (ACTUAL)
- **Why stopped:** recommended by DSMB
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02715466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02715466, "Gelatin in ICU and Sepsis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02715466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*